Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-03-02
1991-11-05
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 21, A61K 3724, A61K 3736, A61K 3738
Patent
active
050632043
ABSTRACT:
A combination of gonadotrophins and growth hormone is useful for treating infertility in higher mammals and humans since the probability of pregnancy is enhanced. In the treatment, gonadotrophins and growth hormone are injected separately, or a combined preparation containing both of these active substances may be used.
REFERENCES:
Goodman & Gilman, The Pharmaceutical Basis of Therapeutics, 3rd Ed., The Macmillan Co., N.Y. 1965, pp. 1532-1533.
JiA et al., Endocrinology, 118, No. 4, 1401 (1986).
Insulin-Like Growth Factors; Endocrine Reviews 6:400, Adashi et al.
Inhibin and Beta type . . . B B R C 136:969 Shao-Yao Ying 136:969 (1986).
Growth Hormone Increase . . . Encocrinology 116:885 (1986) Davoren and Hsueh.
Population Study of Causes . . . British Med. J, 291:1693 (1985) Hull et al.
Growth Hormone Enhances FSH Induced Differentation of Cultured Rat . . . , Xiao-Chi Jia et al., Endocrinology 118:1401 (1986).
Moezie F. T.
Nordisk Gentofte A/S
LandOfFree
Process for treating infertility does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for treating infertility, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for treating infertility will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-499306